The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

Share Price Information for K3 Business Technology Group (KBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.941%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
KBT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Announcement

17 Oct 2022 10:46

RNS Number : 104D K3 Business Technology Group PLC 17 October 2022 160

AIM: KBT

17 October 2022

160

K3 Business Technology Group plc

("K3", "Company" or "Group")

PDMR Announcement

K3, which provies business8208critical software solutions focuse on fashion an apparel brans, has receive notification from Kestrel Partners LLP ("Kestrel") that on 14 October 2022 it acquire, on behalf of its iscretionary clients, 1,00 orinary shares of 2p each ("Shares") in the Company at a price of 1631.23 per Share.

Mr Scott, a non-executive irector of K3, is a partner of, an hols a beneficial interest in Kestrel. Mr Scott is also a shareholer in one of Kestrel's clients ("Kestrel Opportunities") an is therefore eeme to have a beneficial interest in Kestrel Opportunities' entire legal holing in the Company.

Following these transactions, Kestrel Opportunities hols (an consequently Mr Scott is eeme to have a beneficial interest in) 8,1,879 Shares in the Company, an other clients of Kestrel, in which Mr Scott has no beneficial interest, hol 2,837,608 Shares in the Company.

On a combine basis, Kestrel inirectly hols voting rights over 11,33,487 Shares in the Company, which represents 2.38% per cent of the Company's issue share capital.

Kestrel's interest in the Shares in the Company is hel through the following nominees:

Holing type

Nominee

No. of shares

% of issue share capital

Inirect

Bank of New York Nominees Lt

8,1,879

19.04%

Inirect

JIM Nominees Limite

246,171

0.%

Inirect

Bank of New York Nominees Lt

2,91,437

.79%

Further etails in respect of the purchase are provie below, in accorance with the EU Market Abuse Regulation (No 96/2014).

160

For further information contact:

K3 Business Technology Group plc

+44 (0) 161 876 4498

Marco Vergani, CEO

Rob Price, CFO

finnCap Lt

+44 (0) 207 220 000

Nominate Aviser an Broker

160

Julian Blunt/James Thompson (Corporate Finance)

160

Richar Chambers/ Sunila e Silva (Corporate Broking)

160

160

KTZ Communications

+44 (0) 20 3178 6378

160

Katie Tzouliais/Dan Mahoney

160

160

160

160

ANNEX

160

Template for notification an public isclosure of transactions by persons ischarging managerial responsibilities an persons closely associate with them

160

1

160

Details of the person ischarging managerial responsibilities / person closely associate

a)

Name

Kestrel Partners LLP ('Kestrel')

2

Reason for the notification

a)

160

Position/status

160

PCA - Oliver Rupert Anrew Scott (non-executive irector of K3 Business Technology Group plc an Partner in Kestrel)

b)

160

Initial notification /Amenment

Initial

3

160

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

K3 Business Technology Group plc

b)

LEI

213800QOJ9OF2AV81748

4

160

Details of the transaction(s): section to be repeate for (i) each type of instrument (ii) each type of transaction (iii) each ate an (iv) each place where transactions have been conucte

a)

160

Description of the financial instrument, type of instrument

160

Ientification coe

2p Orinary Shares

160

160

160

ISIN: GB00B00P6061

b)

Nature of the transaction

Purchase

c)

160

Price(s) an volume(s)

160

160

Price(s)

160

Volume(s)

1631.23

1,00

)

160

Aggregate information

160

160

- Aggregate volume

160

160

- Price

Total purchase of 1,00 at 1631.23 per Share

160

160

160

e)

160

Date of the transaction

14 October 2022

f)

160

Place of the transaction

Lonon Stock Exchange, AIM Market (XLON)

160

This information is provie by RNS, the news service of the Lonon Stock Exchange. RNS is approve by the Financial Conuct Authority to act as a Primary Information Provier in the Unite Kingom. Terms an conitions relating to the use an istribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP aress to confirm compliance with the terms an conitions, to analyse how you engage with the information containe in this communication, an to share such analysis on an anonymise basis with others as part of our commercial services. For further information about how RNS an the Lonon Stock Exchange use the personal ata you provie us, please see our Privacy Policy.160 END160160DSHGCBDGSSBDGDR
Date   Source Headline
26th Apr 20247:00 amRNSPosting of Annual Report and Notice of AGM
8th Apr 202410:50 amRNSPDMR Announcement
2nd Apr 20244:00 pmRNSPDMR Announcement
26th Mar 20247:00 amRNSFinal Results
29th Jan 20241:00 pmRNSPDMR Announcement
15th Jan 202410:00 amRNSPDMR Announcement
20th Dec 20237:00 amRNSTrading Update
19th Dec 20238:52 amRNSPDMR Announcement
21st Nov 20237:00 amRNSPDMR Announcement
30th Oct 20237:00 amRNSBoard Changes
30th Aug 20237:00 amRNSInterim Results
21st Jul 20235:50 pmRNSPDMR Announcement
7th Jul 20235:10 pmRNSPDMR Announcement
30th Jun 20235:15 pmRNSPDMR Announcement
23rd Jun 20236:00 pmRNSPDMR Announcement
19th Jun 20237:00 amRNSPDMR Announcement
30th May 20231:30 pmRNSPDMR Announcement
23rd May 202311:15 amRNSResult of AGM
19th May 20235:52 pmRNSHolding(s) in Company
19th May 20235:45 pmRNSPDMR Announcement
19th May 20232:45 pmRNSHolding(s) in Company
18th May 202312:58 pmRNSHolding(s) in Company
18th May 202312:45 pmRNSHolding(s) in Company
18th May 202312:40 pmRNSPDMR Announcement
9th May 20237:28 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
28th Apr 20234:07 pmRNSPosting of Annual Report and Notice of AGM
12th Apr 202312:57 pmRNSDirector/PDMR Shareholding
3rd Apr 20231:30 pmRNSPDMR Announcement
30th Mar 20237:00 amRNSFinal Results
30th Mar 20237:00 amRNSBoard Appointment
7th Mar 20237:00 amRNSLargest Order Win for Flagship Fashion Product
6th Feb 202310:00 amRNSPDMR Announcement
23rd Jan 202311:10 amRNSPDMR Announcement
12th Jan 20237:00 amRNSTrading Update
28th Nov 20225:07 pmRNSHolding(s) in Company
28th Nov 20225:05 pmRNSPDMR Announcement
21st Nov 20225:40 pmRNSPDMR Announcement
14th Nov 202212:50 pmRNSPDMR Announcement
7th Nov 20223:53 pmRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
20th Sep 20224:45 pmRNSPDMR Announcement
12th Sep 20225:31 pmRNSPDMR Announcement
24th Aug 20227:00 amRNSInterim Results
26th Jul 20227:00 amRNSBoard Appointment
19th May 202210:57 amRNSResult of AGM
18th May 20225:27 pmRNSK3 LTIP Option Scheme
16th May 202210:42 amRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.